Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

al revenues of $2.1 million, compared with a net loss of $60.0 million, or $1.12 per basic and diluted share, on total revenues of $2.1 million for the same period in 2008. The net loss for the nine months ended September 30, 2009 includes a non-cash charge of $24.1 million due to a valuation adjustment relating to warrants that we issued in connection with our April 2009 registered direct offering. On a non-GAAP basis, excluding the $24.1 million non-cash charge, our net loss for the first nine months of 2009 was $66.5 million, or $1.15 per basic and diluted share, compared with a GAAP net loss of $60.0 million for the nine months ended September 30, 2008, or $1.12 per basic and diluted share.

Financial Results of Operations for the Three Months Ended September 30, 2009

Total revenues for the third quarter of 2009 were $0.3 million compared with $0.5 million for the third quarter of 2008, a decrease of $0.2 million mainly due to lower gross sales of Oxandrin® as a result of decreased overall demand for the product from increased generic competition. Additionally, we adjusted our Oxandrin product return reserve in both the current and prior year quarters to reflect higher actual return experience. We expect that sales of Oxandrin will continue to decline slightly or remain flat in future periods. The decrease in Oxandrin sales was partially offset by a $0.1 million increase in sales of our authorized generic oxandrolone, due to increased market share being achieved by Watson Pharmaceuticals, Inc. (Watson), our authorized generic distributor.

Research and development expenses for the third quarter of 2009 were $17.7 million, compared with $10.9 million for the third quarter of 2008, an increase of $6.8 million, or 62%. The increase is primarily due to $4.5 million in contingency charges recorded in the third quarter of 2009 relating to amending the fee schedule and total obligation under our services agreement with
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... LAVAL, Quebec , Sept. 1, 2015 /PRNewswire/ ... and TSX: VRX) today announced that its affiliate ... under which Valeant was granted an exclusive license ... Brodalumab is an IL-17 receptor monoclonal antibody in ... psoriatic arthritis. Under the agreement, Valeant will hold ...
(Date:8/31/2015)... 31, 2015  DICOM Grid,  the #1 medical ... was recognized as a semifinalist for a Minnie ... The awards are sponsored by Auntminnie.com, a comprehensive ... the medical imaging industry.  Since 1999, the "Minnies" ... acknowledge the contributions of their peers. Nominations are ...
(Date:8/31/2015)... 2015  Chiasma, Inc. (NASDAQ: CHMA ), ... for the orphan condition acromegaly, today reported financial ... 2015 and provided a corporate update. ... time for Chiasma, as we successfully completed our ... first New Drug Application (NDA) has been accepted ...
Breaking Medicine Technology:Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER TOLEDO is ... With the Connectivity Kit, EasySampler data is automatically transferred to, and reported ... on a touchscreen platform. , EasySampler fully automates the sampling process ...
(Date:9/1/2015)... Cincinnati, OH (PRWEB) , ... September 01, 2015 , ... ... Kentucky – has devoted the 10th of its monthly Mercy Health: Helping You Be ... America, affecting one in seven men. , In a concise video on Mercy ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... Ogawa’s ... makes the massage robots more effective and humanlike than ever before. With the goal ... the Ogawa Refresh and the Ogawa Active SuperTrac. , As in its name, ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... ... discount cards, launched its consumer-friendly, informational video this week to coincide with back-to-school ... http://www.USAMedicalCard.com/video . , According to the CDC, elementary school children are sick ...
(Date:9/1/2015)... ... September 01, 2015 , ... Éminence ... of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural peel solutions ... Calm, and Clear. , Formulated with alpha hydroxy acids and natural active ...
Breaking Medicine News(10 mins):Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3
... need to modernize government efforts , , THURSDAY, April 9 ... years, the incidence of many foodborne illnesses in the ... officials announced Thursday. , "Progress has plateaued," Dr. Robert ... and Mycotic Diseases at the U.S. Centers for Disease ...
... Pet Owners to Safeguard Their Pets from a Silent Killer ... Legacy Foundation(R) is challenging pet owners to quit smoking for ... Prevention of Cruelty to Animals Month. A growing body of ... secondhand smoke -- for humans or for animals ...
... Event to Feature Remarks by Rabbi Capers Funnye, Profiled in ... 9 According to the National Institute of Mental Health, ... diagnosed with depressive disorder in any given year and many ... commit suicide. These critical issues and others will be the ...
... ,Help is Here Express, bus tour will be stopping ... April 17 at various cities in order to help ... provide prescription medicines for free or nearly free. With ... Partnership for Prescription Assistance (PPA) is ready to help ...
... University Medical Center is testing a new procedure for ... relieve the pain of osteoarthritis. Rush is the ... III clinical trial. , The procedure, called the Cartilage ... healthy tissue that remains in the knee, breaking it ...
... a neurobiological condition which is often responsive to Applied ... fail to provide this medically necessary service to their ... as the Mental Health Parity Act, has been on ... obliges private health insurance companies to offer treatment services ...
Cached Medicine News:Health News:Declines in Foodborne Illness Have Plateaued, Report Says 2Health News:Tobacco is Toxic for Toto Too 2Health News:Tobacco is Toxic for Toto Too 3Health News:'Shattering Myths: Men, Boys, and Mental Health,' the Focus of Eighth Annual Conference Hosted by the Naomi Ruth Cohen Institute for Mental Health Education at The Chicago School of Professional Psychology, May 31 2Health News:'Shattering Myths: Men, Boys, and Mental Health,' the Focus of Eighth Annual Conference Hosted by the Naomi Ruth Cohen Institute for Mental Health Education at The Chicago School of Professional Psychology, May 31 3Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Arkansas Workers Hurt by Recession 4Health News:Study assesses new surgical procedure for regenerating cartilage in damaged knee joints 2Health News:Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments 2Health News:Uncovering the Secrets of Getting California Health Insurance to Pay for Autism Treatments 3
... years of experience in providing versatile ... Sciences, the Freedom EVO platform delivers ... expansion according to future needs., ,Together ... EVOware, each system is equipped to ...
... A flexible liquid ... simultaneously automate functionality of ... handlers all on the ... preconfigured in smart solutions ...
... The Centra B+ can be used as ... to the Centra W for AHG spins, or ... of 2 rotors, transparent cell washing rotor: easy ... 2 braking options, aerosol containment for vacutainers, glove ...
Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....
Medicine Products: